FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

Barr publishes its offer for Pliva acquisition in Croatian press

ZAGREB, Aug 14 (Hina) - The US company Barr Pharmaceuticals, Inc. on Monday published in major Croatian newspapers its formal offer for the purchase of 100% of the shares of the Croatian drugs company Pliva. Under the offer, Pliva shareholders who tender their shares will receive HRK 743 per share in cash.
ZAGREB, Aug 14 (Hina) - The US company Barr Pharmaceuticals, Inc. on Monday published in major Croatian newspapers its formal offer for the purchase of 100% of the shares of the Croatian drugs company Pliva. Under the offer, Pliva shareholders who tender their shares will receive HRK 743 per share in cash.

The offer was published by the European branch of the Barr Group, Barr Laboratories Europe, based in the Netherlands. Apart from daily press, the offer will also be published in the Offical Gazzete.

The publication of the Company's offer in the Official Gazette initiates the formal tender process, which is expected to take a minimum of 30 days following publication in the Official Gazette and up to 60 days from the date that a competing bid is approved for publication by the Croatian Financial Services Supervisory Agency (HANFA).

Barr's ability to close its tender offer is only conditioned upon the company receiving acceptances that result in Barr holding more than 50% of Pliva shares.

VEZANE OBJAVE

An unhandled error has occurred. Reload 🗙